ACUTE HAEMORRHAGIC CONJUNCTIVITIS

ACUTE HAEMORRHAGIC CONJUNCTIVITIS was reported 30 times

ACUTE HAEMORRHAGIC CONJUNCTIVITIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 3 0.0001
1 Prostacyclin Receptor Agonist [EPC] 2 0.0001
2 Protease Inhibitor [EPC] 3 0.0001
3 Cytochrome P450 3A Inhibitor [EPC] 3 0.0000
4 Alkaloid [EPC] 1 0.0000
5 Interleukin-17A Antagonist [EPC] 1 0.0000
6 Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 3 0.0000
7 Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 3 0.0000
8 Epidermal Growth Factor Receptor Antagonist [EPC] 1 0.0000
9 Macrolide Antimicrobial [EPC] 1 0.0000
10 Proteasome Inhibitor [EPC] 2 0.0000
11 Phosphodiesterase 5 Inhibitor [EPC] 2 0.0000
12 Tetracycline-class Drug [EPC] 1 0.0000
13 Catecholamine [EPC] 1 0.0000
14 Purine Antimetabolite [EPC] 1 0.0000
15 Endothelin Receptor Antagonist [EPC] 2 0.0000
16 Aminosalicylate [EPC] 1 0.0000
17 Dihydropyridine Calcium Channel Blocker [EPC] 3 0.0000
18 Nonsteroidal Anti-inflammatory Drug [EPC] 10 0.0000
19 Kinase Inhibitor [EPC] 4 0.0000
20 Vascular Endothelial Growth Factor Inhibitor [EPC] 1 0.0000
21 RANK Ligand Inhibitor [EPC] 1 0.0000
22 Alkylating Drug [EPC] 1 0.0000
23 Platinum-based Drug [EPC] 1 0.0000
24 Nucleoside Metabolic Inhibitor [EPC] 1 0.0000
25 Factor Xa Inhibitor [EPC] 1 0.0000
26 Vitamin D [EPC] 1 0.0000
27 CD20-directed Cytolytic Antibody [EPC] 1 0.0000
28 Angiotensin 2 Receptor Blocker [EPC] 1 0.0000
29 Corticosteroid [EPC] 4 0.0000
30 Vitamin B12 [EPC] 1 0.0000
31 Vitamin C [EPC] 1 0.0000
32 Interleukin-4 Receptor alpha Antagonist [EPC] 1 0.0000
33 Platelet Aggregation Inhibitor [EPC] 1 0.0000